Cargando…
Identification of novel diagnostic biomarkers for thyroid carcinoma
Thyroid carcinoma (THCA) is the most universal endocrine malignancy worldwide. Unfortunately, a limited number of large-scale analyses have been performed to identify biomarkers for THCA. Here, we conducted a meta-analysis using 505 THCA patients and 59 normal controls from The Cancer Genome Atlas....
Autores principales: | Wang, Xiliang, Zhang, Qing, Cai, Zhiming, Dai, Yifan, Mou, Lisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762342/ https://www.ncbi.nlm.nih.gov/pubmed/29340074 http://dx.doi.org/10.18632/oncotarget.22873 |
Ejemplares similares
-
Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors
por: Ren, Yanming, et al.
Publicado: (2018) -
Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation
por: Zhou, Ming, et al.
Publicado: (2016) -
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019) -
Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
por: Wang, Zhiyang, et al.
Publicado: (2023) -
ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma
por: Lin, Xu, et al.
Publicado: (2021)